Organogenesis Holdings Inc（ORGO）今日盘前大跌7.08%，主要原因是公司公布的第二季度财报不及市场预期。
根据公司最新发布的财报显示，截至6月30日的季度，Organogenesis Holdings每股亏损10美分，远低于分析师平均预期的亏损6美分。同时，公司营收为1.0101亿美元，同比下降22.4%，也未能达到分析师预期的1.034亿美元。这一业绩表现明显低于市场预期，导致投资者信心受挫。
值得注意的是，尽管公司股价在本季度上涨了23.0%，今年迄今为止更是上涨了40.6%，但此次业绩不佳可能会影响投资者对公司未来增长前景的判断。分析师对公司的平均评级仍为"买入"，12个月目标价中位数为7.00美元，较上一交易日收盘价4.52美元高出约35.4%。然而，考虑到此次业绩表现，市场可能需要重新评估公司的短期发展前景。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.